Histone deacetylase (HDAC) inhibitors sodium butyrate and trichostatin A arrest human papillomavirus (HPV)-positive carcinoma cells in G1 to S transition of the cell cycle, which is paralleled by an up-regulation of the cyclin-dependent kinase inhibitors (CKIs) p21
Introduction
Modulation of histone acetylation is an integral part of a regulatory mechanism, which is involved in the nucleosomal organization of the bulk cellular DNA. Post-translational neutralization of the positive charge of lysine residues within the N-terminal domain of core histones relieves histone-DNA interactions, which in turn facilitates the accessibility of transcription factors with their cognate regulatory elements at the DNA level (for review, see Workman and Kingston, 1998) .
Alterations of the chromatin architecture is mediated by an interplay between histone acetylases (HAT) and deacetylases (HDAC) counteracting each other in either activating or repressing gene expression (for review, see Wade et al., 1997) . During the last years, a substantial number of HATs have been characterized in yeast and Tetrahymena (Parthun et al., 1996; Wu, 1997) . In higher eukaryotes, particular adaptor molecules such as p300/CBP or p/CAF (termed as p300/ CPB-associated factor) possess intrinsic HAT activity. Their association with CREB, c-jun, c-fos or unliganded nuclear receptors provides a functional linkage between transcriptional co-activators and histone acetylators during initiation of gene expression (Workman and Kingston, 1998) . Conversely, histone deacetylase type 1 (HDAC1) is an inherent component of a general corepressor complex which interacts with YY-1, Mad/Max as well as the retinoblastoma protein pRb, regularly leading to inhibition of gene expression, although exceptions exist (Workman and Kingston, 1998; Wade et al., 1997) . Since both HATs and HDACs by themselves have no sequence-speci®c DNA-binding anities, physical interaction with transcriptional activators or repressors provides a reliable explanation by which enzymes, normally acting entirely in a global way during nucleosomal remodelling, can be speci®ed to locally de®ned transcription units.
Not only cellular transcription factors can target HAT and HDAC molecules, but also viral oncoproteins such as E6 and E7 of the`high-risk' human papillomaviruses (HPV), the etiological agents of cervical cancer (for review, see zur . As shown recently, HPV 16 E6 is capable of abrogating the co-stimulatory function of CBP and p300, resulting in a decreased ability of these factors to trans-activate p53-, NF-kB-and c-jun-responsive promoter elements (Patel et al., 1999) . While E6 interferes with the CBP/ p300 tethering function to other transcription factors and possibly with intrinsic HAT activity, E7 oncoprotein can indirectly bind to the histone deacetylase complex via the bridge-protein Mi2b (Brehm et al., 1999) . This property presumably enables E7 to inactivate cellular genes incompatible with the outgrowth of premalignant cells during development of cervical cancer. For example, the interferon-regulatory factor-1 (IRF-1) gene, whose expression is important for interferon signalling and immunological surveillance of persisting HPV infections (for review, see RoÈ sl et al., 1999) , is silenced via an E7-mediated recruitment of HDAC to the respective promoter (Park et al., 2000) . Depending on the interplay between dierent transcription factors, E7 can also act in an opposite way. For example, E7 relieves the repressive eect of pRb and HDAC1 on the cyclin E promoter thereby promoting unscheduled cell cycle progression (Brehm et al., 1998) .
Another hallmark of HPV-induced transformation is the post-translational interaction of E6 and E7 with cellular proteins engaged in cell cycle control: E6 binds to p53 and promotes its degradation via the ubiquitin/ proteasome pathway. E7 complexes with the retinoblastoma protein pRb, p107, p130, cyclin A, cyclin E as well as the cyclin-dependent kinase inhibitors p21 CIP1 and p27
KIP1 (for review, see zur . These proteins not only play an important role in G1 checkpoint control (Sherr, 1996; Weinberg, 1995) , but depending on the cell system, some of them can also be modulated in their expression and function by inhibitors of histone deacetylase (HDAC) such as sodium butyrate or trichostatin A. Indeed, HDAC inhibitors have received much attention during the last years due to their capability to induce cell dierentiation, growth arrest and apoptosis (Newmark et al., 1994; Janson et al., 1997) .
In order to elucidate the molecular eects of histone deacetylase inhibition in the context of HPV 16/18-induced carcinogenesis, we used the HPV 18-positive cervical carcinoma cell line HeLa as well as primary human foreskin keratinocytes, which were separately immortalized with amphotropic retroviruses carrying the open reading frames of HPV 16 E6, E7 or E6/E7. In the present study we show that sodium butyrate (as well as trichostatin A) strongly inhibit G1 to S transition in HPV-positive cells by modulation of cell cycle regulatory proteins and restoration of cdk2 inhibitory function even in the presence of viral oncogenes. Longer treatment induces apoptosis, which was selective for E7 expressing cells. These data suggest that HDAC inhibitors may be useful drugs for cervical cancer therapy, because HPV oncogene function can be circumvented.
Results
Histone deacetylase inhibitors induce G1/S phase arrest in HPV 18-positive cervical carcinoma cells despite ongoing E6/E7 synthesis In order to assess the speci®c impact of histone deacetylase inhibition on cell proliferation,¯ow cytometric analysis of cellular DNA content was carried out (Figure 1 ). Treatment with 6 mM sodium butyrate for 16 h resulted in a signi®cant increase of the G1 fraction (from 56.8 to 75.7%), whereas the number of cells in S phase was diminished (from 24.9 to 8.5%). As previously shown, continuous expression of the viral oncogenes seems to be necessary to maintain the proliferative phenotype of cervical carcinoma cells (von Knebel Doeberitz et al., 1988) . To address the question whether HDAC inhibitors also have consequences on the transcriptional activity of endogenous HPV 18 genomes in HeLa cells, Northern blot analysis was performed. Although time course experiments reproducibly revealed an initial downregulation of viral E6/E7 expression shortly after sodium butyrate addition, the eect was only transient (data not shown). However, under conditions where cells became growth arrested (Figure 1a) , still ongoing HPV 18 transcription ( Figure 1b ) and E7 oncogene expression could be discerned (Figure 1c ). It should be stressed that similar results were obtained with trichostatin A (data not shown), indicating that HDAC inhibitors in general are able to arrest proliferation of cervical carcinoma cells by circumventing and/or neutralizing viral oncoprotein function (see below).
HDAC inhibitors modulate cyclins but not cdk expression
Because the precise mechanism underlying the growth inhibitory eect on cervical carcinoma cells has not yet been established, we went on to examine the steadystate levels of regulatory proteins involved in cell cycle Western blot analysis. Seventy-®ve mg of total cellular protein was loaded on a 12% SDS ± PAGE gel. After electrotransfer, the ®lters were consecutively incubated with HPV 18 E7 and a monoclonal actin antibody. (7): untreated cells; (+): treated with 6 mM sodium butyrate for 16 h control. As shown in Figure 2 , sodium butyrate selectively down-regulates cyclin D1 and cyclin A, while the amount of cyclin E was strongly increased (Figure 2a) . Incubation of the same ®lter with a monoclonal actin antibody con®rmed equal loading and protein transfer. Quantitative dierences of cyclin expression after sodium butyrate application were presumably not due to altered degradation rates (see below), since there was a good accordance between the levels of protein and the corresponding mRNAs (Figure 2c ). Control hybridization of the identical blot with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) again corroborated the selectivity of this eect. In contrast, neither the cyclin-dependent kinase 2 (cdk2) nor cdk4 or cdk6 revealed any signi®cant in¯uence on their expression rates (Figure 2b ), clearly excluding the possibility that the growth-inhibitory eect could be attributed to a mere reduction of the intracellular amounts of certain cdks.
Sodium butyrate induces cyclin-dependent kinase inhibitor p21
CIP1 on transcriptional level, while p27 KIP1 is upregulated post-translationally by concomitant suppression of p45 SKP2 , a component of the ubiquitin ± protein ligase SCF
SKP2
In a next set of experiments, we measured the levels of cyclin-dependent kinase inhibitors (CKIs), which are known mediators of cell cycle arrest upon various antiproliferative signals (Hengst and Reed, 1998; Carnero and Hannon, 1998) . Western blot analysis of cellular extracts (Figure 3a) demonstrates that the Cip/ Kip family members p21 CIP1 and p27
KIP1
, which normally block cyclin A/cdk2 and cyclin E/cdk2 function (Hengst and Reed, 1998) , were signi®cantly induced after sodium butyrate treatment. In contrast, upon examining the same extracts for the cyclin D1-cdk4/6 inhibitor p16
INK4 (Carnero and Hannon, 1998) , no reduction was discerned. Surprisingly, monitoring the steady-state levels of the corresponding mRNAs, only p21
CIP1 was increased, while p27 KIP1 expression was even diminished under the same experimental conditions. To understand this apparent discrepancy, we Figure 2 Eects of sodium butyrate on the expression of G1 cyclins and cyclin-dependent kinases (cdks). (a and b) Exponentially growing HeLa cells were treated with sodium butyrate (NaB) as indicated in Figure 1 . Fifty mg of protein was separated on 12% SDS ± PAGE minigels. After electrotransfer, the ®lters were incubated with antibodies against cyclin D1, cyclin E, cyclin A or cdk2, cdk4 and cdk6 speci®c antibodies. Equal protein loading was con®rmed by reincubating the ®lters with a monoclonal actin antibody. (c) Northern blot analysis. Five mg of RNA was separated in a 1% agarose gel. The ®lters were hybridized with cDNAs encoding cyclin D1, cyclin E, cyclin A and GAPDH. The positions of the 28S and 18S ribosomal RNA are indicated. (7): untreated cells; (+): treated with 6 mM sodium butyrate for 16 h , 1999; Carrano et al., 1999) . p45 SKP2 which is found to be upregulated in many transformed cells (Zhang et al., 1995) , became strongly suppressed after addition of sodium butyrate (Figure 3a) . Reduction was accompanied by a decrease of the corresponding mRNA, but not to such an extent as detected for the protein (data not shown). These data strongly imply that at least one major cell growth inhibitory function of histone deacetylase inhibitors can be attributed to the posttranslational stabilization of the cdk2 inhibitor p27 KIP1 via disturbance of the SCF (SKP-1-CDC53-F-box) ubiquitin protein ligase complex (see Discussion).
Cdk2 activity is completely suppressed after butyrate treatment: exclusion of E7 from the complex
Cdk2 inhibitors such as p21
CIP1 and p27 KIP1 play an important role during immortalization and cellular transformation by potential DNA tumourviruses, because their function can be neutralized or bypassed after binding of viral oncoproteins such as E7 (zur . To analyse whether cdk2 activity was modulated after addition of sodium butyrate, cyclincdk2 complexes were ®rst immunoprecipitated using speci®c antibodies directed against the C-terminal domain of cdk2, and subsequently assayed in vitro using histone H1 as substrate (Figure 4a ). In comparison with the untreated control, cdk2 kinase activity was completely abolished 16 h after sodium butyrate addition. Time course experiments performed in parallel showed that cdk2 was still active after 9 h, but abruptly declined 3 h later (data not shown). To test whether or not p21
CIP1 and p27 KIP1 in fact bind to the cdk2 complex, the composition pattern of the cdk2 immunoprecipitates was examined by Western blot analysis. As depicted in Figure 4a ,c, cdk2 activity was abrogated under conditions where both CKIs became associated with the cdk2 complex. In contrast, E7 that was readily detectable in untreated control cells, completely disappeared in the treated cells though the total intracellular net amount of the viral oncoprotein did not change (Figure 4d , see also Figure 1c , for comparison). Reincubation of the same immunoblots with a cdk2 antibody con®rmed that equal amounts were precipitated (Figure 4e ). Taken together, these data indicate that transition from a proliferative to a quiescent phenotype apparently require at least two steps: functional abolition of cdk2 activity by p21 CIP1 and p27
KIP1 as well as concomitant prevention of E7 binding.
Differential pRb inactivation in the presence of individual oncoproteins: the role of histone deacetylase inhibitors in the induction of apoptosis
The most studied G1 speci®c cyclin/cdk substrate is the retinoblastoma protein pRb (Weinberg, 1995) , which can recruit HDAC1 to repress cell cycle regulatory proteins such as cyclin E (Brehm et al., 1998) . Since cyclin E was signi®cantly up-regulated by sodium butyrate, it was mandatory to examine the fate of pRb in our experimental cell systems. Figure 5b illustrates that pRB became totally degradated after 16 h, but histone deacetylase inhibition obviously has no consequences on gene expression and translation of the transcription factor E2F-1. Instead, the absence of pRb could be clearly attributed to a post-translational event, because the steady-state level of the corresponding mRNA was maintained (Figure 5a ). The lack of a modulatory eect on p53 (Figure 5c ), whose half-life is controlled by E6 (Schener et al., 1990) , con®rmed the previous ®nding that viral oncoprotein expression is sustained in the presence of sodium butyrate (see Figure 1c) .
The strong degradation of the anti-apoptotic protein pRb (Haas-Kogan et al., 1995) without any reduction of the transcription factor E2F-1 presumably accounts for the ®nal appearance of the distinct apoptotic ®gures such as membrane blebbing, detachment from the surface and karyorhexis after longer HDAC inhibition. The start of apoptosis can already be detected after 16 h using a highly sensitive ELISA assay, which measures the release of histone-associated- CIP1 (b), p27 KIP1 (c) and HPV 18 E7 speci®c antibodies (d). Equal loading was veri®ed by incubation with cdk2 antibodies (e). PI: preimmune serum. Contr.: untreated cells; NaB: treated with 6 mM sodium butyrate for 16 h DNA-fragments in the cytoplasm after nuclear breakdown (Figure 5d ). Longer treatment (up to 36 h) results in the appearance of a typical sub-G1 peak, which could be discerned by FACS analysis (data not shown).
While E2F-1 did not signi®cantly vary in HPV 16-immortalized human keratinocytes, pRb degradation seems to be strictly dependent on the presence of E7. As shown in Figure 6 , pRb completely disappeared exclusively in E7-expressing cells, while it is only seen to be hypophosphorylated in cells containing E6 as viral oncogene. E6/E7-immortalized keratinocytes again revealed pRb degradation, clearly showing that the fate of pRb is determined by E7 in a dominant fashion. Biological availability of pRb can be followed by monitoring the expression level of cyclin E, whose transcription is negatively regulated by pRb (Brehm et al., 1998) . The reason for cyclin E expression in untreated E7-positive cells is consistent with the ability of E7 to overcome the pRb suppressive eect on the cognate promoter by destroying the pRb-HDAC1 complex (Brehm et al., 1998) . Most notably, carrying out FACS analyses after longer incubation, only E7-positive keratinocytes underwent apoptosis (Figure 7d,  f) . Quantifying the number of apoptotic cells within the sub-G1 peak after FACS analysis, E7-keratinocytes were found to be highly susceptible (Figure 7d ), followed by E6/E7-expressing cell (Figure 7f ). In contrast, keratinocytes expressing E6 alone were completely resistant under the same experimental conditions (Figure 7b ), suggesting that pRb destruction and the commitment to undergo apoptosis might be functionally linked.
Discussion
To unravel the molecular mechanism of histone deacetylase inhibition on human papillomavirus (HPV)-transformed cells, we used a HPV 18-positive cervical carcinoma cell line (HeLa) and human keratinocytes as model systems, which were separately immortalized by individual oncogenes derived from HPV 16 (Whitaker and zur Hausen, unpublished) . In the present study we show that sodium butyrate (as well as trichostatin A) can eciently abrogate G1 to S transition ( Figure 1a ) despite still ongoing viral gene expression (Figure 1b,c) . As a consequence, programmed cell death is induced, which we con®rmed using a sensitive ELISA assay to detect beginning nucleosomal release into the cytoplasm after nuclear breakdown (Figure 5d ).
In detail, monitoring cell cycle regulatory proteins, it became evident that sodium butyrate can modulate the expression of both cyclins and cyclin-dependent kinase (cdk) inhibitors (Figures 2 and 3) . One of the ®rst cyclins that is expressed when quiescent cells re-enter the cell cycle is cyclin D1 (Sherr, 1993) . Cyclin D1 Fifty mg of protein was separated in 8% (for pRb) and 12% SDS ± PAGE gels. After electrotransfer, the ®lters were incubated with pRb, E2F-1 (b) and (c) p53 speci®c antibodies. Equal protein loading was con®rmed with a monoclonal actin antibody. (d) Quanti®cation of apoptosis using a commercially available`Cell Death Detection ELISA' kit. The enrichment factor, for untreated control cells arbitrarily set as 1, directly re¯ects the extent of apoptosis in HeLa cells after treatment with sodium butyrate for 16 h Figure 6 pRB degradation by sodium butyrate in HPV 16 immortalized keratinocytes is E7 dependent. Western blot analysis of cellular extracts obtained from E6-, E7-, and E6/E7-immortalized cells were separated in 8% (pRb) and 12% SDS ± PAGE gels. After electrotransfer, the ®lters were incubated with pRb, E2F-1, cyclin E and actin antibodies. (7): untreated cells; (+): treated with 6 mM sodium butyrate for 16 h. Due to quantitative dierences of pRb and cyclin E levels in E7-and E6/ E7-positive cells, the ®lters were exposed for dierent times behaves as a positive regulator of G1 progression by antagonizing the growth suppressing function of the retinoblastoma protein pRb (Weinberg, 1995) . Intriguingly, histone deacetylase inhibition reduced not only the amount of cyclin D1, but also cyclin A expression (Figure 2a) . Cyclin A is a known target of the E7 oncoprotein, which mediates the interaction and unscheduled activation of cdk2 in overriding normal G1 checkpoint control (Tommasino et al., 1993) . E7 can directly activate the cyclin A promoter in a cdk2-dependent manner, thereafter facilitating cell cycle progression (Zerfass et al., 1995) . The strong suppression of cyclin A (Figure 2 ) provided a ®rst hint that sodium butyrate was apparently able to negatively interfere with cdk2 activity despite coexisting HPV expression (see below). On the other hand, the late G1 gene cyclin E (Sherr, 1993) , which is normally repressed via a retinoblastoma protein (pRb)-mediated recruitment of type 1 histone deacetylase (Brehm et al., 1998) , was strongly induced under the same experimental conditions (Figure 2 ).
Although cyclin modulation by HDAC inhibitors has previously been reported for other malignant cell lines, the results from these studies are partly contradictory (Lallemand et al., 1996; Siavoshian et al., 1997) . This suggests that even though HDAC inhibition triggers the same growth inhibitory eects, the underlying molecular mechanisms probably depend on the genetic background, the species speci®city and the etiology of the tumour.
We show here that sodium butyrate (and trichostatin A) can circumvent HPV oncogene function via a simultaneous up-regulation of the cdk2 inhibitors p21
CIPI and p27 KIPI (Hengst and Reed, 1998) (Figure  3) . As demonstrated by cdk2-coimmunoprecipitation and subsequent histone H1 kinase assays, enhanced expression of p27
KIPI and more pronounced of p21 CIPI functionally correlated with suppression of cdk2 activity (Figure 4 ). Inhibition of cdk2 activity seems to underlie a speci®c mechanism in cervical carcinoma cells, since Western blot analysis revealed that in the same way p21 CIPI and p27 KIPI became associated with the cdk2 complex, E7 binding was prevented. This has important implications with respect to the reversibility of the transforming potential of`high-risk' HPV types, because it is thought that the abrogation of the growth inhibitory function of both CKIs through E7 binding represents a key regulatory event during the multi-step progression to cervical cancer (for review, see zur . However, it is presently unclear whether both CKIs are necessary to mediate this eect. It is worth noting in this context that p21 CIPI can exist in two physically distinct, catalytically active and inactive forms. p21
CIPI fails to act as a genuine CKI when bound to cdk2 in subsaturating levels (Zhang et al., 1994) , whereas the binding of a single p27 KIPI molecule is obviously sucient to confer inhibition (Russo et al., 1996) .
While at least the induction of p21 CIPI gene expression by HDAC inhibitors can be explained by a p53 independent (Figure 5c ) interplay between the transcription factors Sp1, Sp3 and p300 at the cognate GC-rich promoter region (Xiao et al., 2000) , we currently do not understand the suppressive eect on p27 KIPI transcription (Figure 3b) . Nevertheless, the observation that p27 KIPI was up-regulated despite concomitant transcriptional reduction of the corresponding gene suggests that a post-translationally controlled pathway must be aected. In fact, the biological availability of p27
KIPI is regulated by a phosphorylation-and ubiquitin-dependent mechanism, which is mediated by a new family of adaptor molecules, called F-box proteins (SutterluÈ ty et al., 1999; Carrano et al., 1999) . These distinct adaptors (e.g. p45
SKP2
) are part of the ubiquitin ± protein ligase complex SCF SKP2 and mark proteins for degradation via the 26S proteasome.
The detection of down-regulation of the F-box protein p45 SKP2 (Figure 3a) provides for the ®rst time a functional link between the molecular mechanisms of HDAC inhibition and an intracellular machinery controlling the half-life of cell cycle regulatory proteins such as p27
KIPI . p45 SKP2 is found to be increased in many human cancers (Zhang et al., 1995) , thereby enforcing S phase entry. Moreover, ectopic expression of p45 SKP2 induces not only elimination of p27
KIPI
, but also accumulation of cyclin A (SutterluÈ ty et al., 1999) and premature degradation of E2F . In support of this inverse relationship is the result that the amount of the cyclin A protein became reduced after sodium butyrate addition (Figure 2a,b) . Because the corresponding gene was simultanously suppressed on the mRNA level (Figure 2c) , it is reasonable to assume that p27 KIPI , which is a known negative regulator of cyclin A transcription (Zerfass-Thome et al., 1997) , was also involved in this eect. Conversely, the question still remains why under conditions in which p45
SKP2 was down-regulated, no enhanced E2F levels could be discerned (Figure 5a ). Whether this discrepancy re¯ects an equilibrium between the accumulation of E2F and its preferential degradation when pRb is absent (Figure 5b ) remains to be shown. Although pRb appears to be in fact a speci®c protector of the transcription factor E2F during the period when pRb/E2F complex formation is required for ecient cell cycle control (Hofmann et al., 1996) , its half-life regulation is probably not a monocausal event. This hypothesis can be deduced from recent p45 SKP2 knockout experiments where despite elevated p27
KIPI expression, no increased amounts of E2F were noticed (Nakayama et al., 2000) . Inappropriate release of E2F-1 during pRb degradation (Figure 5b ) and the concomitant block in G1-S transition (Figure 1 ) provide a prerequisite for a classical con¯icting growth situation in which cells start to undergo apoptosis (Almasan et al., 1995) (Figures 5d and 7) .
To establish a more functional link between the fate of pRb and the role of individual HPV-speci®c oncogenes during HDAC inhibition, we used human keratinocytes, which were independently immortalized with amphotropic retroviral vectors carrying either HPV 16 E6 or E7 alone or a complete transcription cassette encoding both proteins. Intriguingly, pRb became completely degraded in E7-expressing cells (Figure 6 ), but was only hypophosphorylated in cells containing E6 as viral oncogene. pRb hypophosphorylation upon treatment with HDAC inhibitors has been also described in other cell systems lacking any DNA tumourvirus etiology (Sambucetti et al., 1999) . Since the metabolic half-life of pRb is inherently controlled by E7 (Jones and MuÈ nger, 1996) , elimination of pRb upon HDAC inhibition seemed also to be determined by E7 in a dominant fashion. The opposite role of E7 and pRb is also re¯ected by the expression level of cyclin E, whose transcription is negatively regulated by pRb (Brehm et al., 1998) , but induced by E7 (Zerfass et al., 1995) . pRb recruits histone deacetylase to E2F-site containing promoters (e.g. cyclin E) and in turn alters the nucleosomal conformation that hinders binding of transcription factors (Luo et al., 1998) . Inhibition of HDAC activity by sodium butyrate or trichostatin A relieves the transcriptional block (Brehm et al., 1998) , thereby inducing cyclin E expression (see Figures 2a and 6 for comparison) . The high baseline expression of cyclin E in untreated E7-positive cells, which could not be further augmented by sodium butyrate treatment, is apparently also due to E7. When present in sucient stoichiometric amounts, E7 can abrogate the pRb suppressive eect on the cyclin E promoter by competition with HDAC1 for the occupancy of the pRb`pocket' domain (Brehm et al., 1998) . Hence, as far as the regulation of cyclin E is concerned, HDAC inhibition and E7 have the same eect.
To explain dierent apoptosis sensitivity of E6-versus E7-and E6/E7-expressing cells, the following scenario can be envisioned: as shown recently, E2F can be acetylated by p/CAF, which has intrinsic HAT activity. Acetylation results in increased DNA-binding anity, trans-activation and prolonged half-life (MartinezBalbas et al., 2000) . However, when bound to pRb, this eect can be eciently reversed by pRb-associated HDAC 1 activity (Brehm et al., 1998) . It is therefore conceivable that enhanced degradation of pRb in E7-positive cells concomitant with HDAC inhibition favours the induction of E2F-responsive genes involved in apoptosis (MuÈ ller et al., 2001) . Conversely, in E6-expressing keratinocytes, HDAC inhibitors may certainly also block deacetylation, but hypophosphorylated pRb prevents the release of E2F and in turn the activation of pro-apoptotic genes, despite associated p/ CAF HAT is probably still active.
In conclusion, the ®nding that inhibition of histone deacetylation can bypass the transforming potential of high-risk' HPV oncoproteins by inducing a block in G1 to S transition and subsequent apoptosis may have important implications for the treatment of cervical cancer.
Material and methods

Cell lines
HPV 18-positive cervical carcinoma cells (HeLa) were maintained in Dulbecco's modi®ed Eagle's medium (DMEM), supplemented with 10% foetal calf serum (Gibco, BRL), 1% penicillin and streptomycin (Sigma). Primary human keratinocytes, immortalized by E6-, E7-and E6/E7-open reading frames carrying amphotroptic retroviruses (Whitaker and zur Hausen, unpublished) were cultivated iǹ Keratinocyte Medium Kit' (Sigma).
Reagents
The sodium salt of the n-butyric acid (Sigma) was freshly resolved and diluted with cultivation medium. Trichostatin A (Sigma) was prepared in dimethylsulphoxid (DMSO) (Merck).
Cell cycle analysis
Cells were harvested by trypsinization, washed twice with phosphate-buered saline (PBS) and ®xed overnight with 70% ethanol. The cells were resuspended in PBS containing 40 mg/ml of DNase-free RNaseA and 50 mg/ml propidium iodide and cell cycle distribution was measured in ā uorescence-activated cell sorter (FACSort) from Becton Dickinson. DNA content was quanti®ed by using the`Cell Quest' software. Flow cytometric quanti®cation of apoptotic cells was exactly done as described (Stoehr et al., 1978) .
RNA extraction and Northern blot analysis
Total cellular RNA was extracted according to the guanidinium-thiocyanate procedure (Chomczynski and Sacchi, 1987) . Approximately 5 mg RNA was separated on 1% agarose gels in the presence of ethidium bromide under nondenaturing conditions and transferred to GeneScreen Plus membranes (DuPont, NEN). The ®lters were hybridized under stringent conditions with speci®c probes, which were labelled with 32 P-dCTP by random priming (Feinberg and Vogelstein, 1984) .
DNA hybridization probes
The cDNAs of p21 (El-Deiry et al., 1993) , p27 (Polyak et al., 1994) , cyclin D1 (Baldin et al., 1993) , cyclin A (Pines and Hunter, 1990) and cyclin E (Hinds et al., 1992) were obtained from P Jansen-DuÈ rr (University of Innsbruck, Austria). The cDNA stretch of pRB (nucleotide 379 ± 928) was obtained from M Tommasino (DKFZ Heidelberg). The GAPDH probe (Ercolani et al., 1988) was obtained from A Alonso (DKFZ, Heidelberg). The unit-length HPV 18 genome was cloned in pBR322 (Boshart et al., 1984) .
SDS ± PAGE and Western blots
Cellular extracts were separated in 8 ± 12% SDS ± PAGE gels and electrotransferred as described elsewhere (Finzer et al., 2000) . The following antibodies were used: cyclin E (HE 12), cyclin D1 (HD 11), cdk2 (M2), cdk4 (C-22), cdk6 (C-21), p27 KIP1 (C-19), p45 SKP2 (N-19), HPV 18-E7 (N-19) and E2F-1 (KH95) (Santa Cruz Biotechnology, Inc.), p21 CIP1 (C24420; Transduction Laboratories), pRB (NCL-RB; Novocastra, UK) and p16 INK4 (15126E, Pharmingen, San Diego CA, USA). Cyclin A was kindly provided by M Pagano (Pagano et al., 1992) via M Tommasino (DKFZ, Heidelberg, Germany). Equal protein transfer and loading was routinely checked by incubating the ®lters with a monoclonal actin antibody (ICN Biomedicals, OH, USA).
Extract preparation, immunoprecipitation and histone kinase assays
For cell fractionation, cell monolayers were washed twice with PBS and harvested by trypsinization. Cell extract preparation and cdk2 activity assays were exactly done as described elsewhere (Blomberg and Homann, 1999) . In addition, cdk2 was immunoprecipitated and analysed by immunoblotting. Beads used for cdk2 kinase assay were washed three times with lysis buer (Blomberg and Homann, 1999) , incubated with Laemmli sample buer and boiled for 5 min. Supernatant was analysed by SDS ± PAGE gels. Immunoblotting was carried out with the following antibodies: p21 CIP1 (C24420) and p27 KIP1 (K25020) (Transduction laboratories) or HPV 18-E7 (N-19) (Santa Cruz, Inc.). Cdk2 speci®c antibodies or preimmune serum were kindly provided by I Homann (DKFZ, Heidelberg, Germany).
Quantification of apoptosis
The rate of apoptosis was determined with the Cell Death Detection kit (ELISA PLUS , Roche Diagnostics; Mannheim, Germany) following the attached instructions of the manufacturer.
